Komori
Nakamoto Packs (7811) · InitiativeR&D spending up, activities continuing

Continuation of Research and Development Activities

First written in FY2017-Q1. 13 of 37 entries say "Restated". Latest entry: FY2027-H1.

37entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018-Q1 – FY2023-Q3OtherFY2024-Q1 – FY2025-H12016: 220162017: 420172018: 420182019: 420192020: 420202021: 420212022: 420222023: 420232024: 320242025: 220252026: 22026
Same theme, other companies
Continuation of Company-wide R&D Activities and Resource InvestmentA theme 204 companies write about · 0 as a headwind · 217 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.Comparing 200 of the theme's 219 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1R&D spending up, activities continuingAnnual report

    「The Group’s total research and development expenditure during the interim consolidated accounting period was ¥93.023 million. There were no material changes in the status of the Group’s research and development activities during the interim consolidated accounting period.」

    While stating that there were no material changes in research and development activities, the company reported that R&D expenditure increased from ¥87.869 million in the same interim period of the previous year to ¥93.023 million.
  2. FY2026AdvancedAnnual report

    「R&D expenditure for the current consolidated fiscal year was ¥176.052 million, and R&D activities were as follows: To strengthen its R&D structure, the Company plans to launch the R&D Coater, a test coating machine, in May 2026.」

    R&D expenditure increased from ¥171.409 million in the previous fiscal year to ¥176.052 million. The Company disclosed that it would continue its environmental initiatives and plans to launch the R&D Coater in May 2026.
  3. FY2026-H1RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative interim period of the current consolidated fiscal year was ¥87.937 million. There were no material changes in the status of the Group's R&D activities during the cumulative interim period of the current consolidated fiscal year.」

    Disclosure of R&D expenditure continued, with a slight increase from ¥87.869 million in the same interim period of the previous year. It is stated that there were no material changes in the status of R&D activities.
  4. FY2025AdvancedAnnual report

    「R&D expenditure for the current consolidated fiscal year was ¥171.409 million, and R&D activities were as follows: (1) Development and sale of RESCⓇ functional coatings for paper; (2) development of environmentally oriented separators; (3) development of insulation materials; (4) development and sale of label-free thermal products; (5) development of peelable laminates; (6) development and sale of Polylami Paper My Ecoro(R), using special resins; (7) development and sale of products promoting the shift to paper.」

    R&D expenditure increased from ¥52.218 million in the previous fiscal year to ¥171.409 million, and specific projects were disclosed, including paper coatings, environmentally oriented separators, insulation materials, label-free thermal products, peelable laminates, and products promoting the shift to paper.
  5. FY2025-H1R&D spending up, activities continuingAnnual report

    「Group-wide R&D expenditure for the cumulative interim period of the current consolidated fiscal year was ¥87.869 million. There were no material changes in the status of the Group's R&D activities during the cumulative interim period of the current consolidated fiscal year.」

    R&D expenditure of ¥87.869 million is disclosed, while it is stated that there were no material changes in the status of R&D activities.
  6. FY2025-Q1R&D spending up, activities continuingAnnual report

    「Group-wide R&D expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥46.039 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」

    Although it is stated that there were no material changes in the status of R&D activities, R&D expenditure increased from ¥16.816 million in the same period of the previous year to ¥46.039 million.
  7. FY2024R&D expenditure down; environmental initiatives expandedAnnual report

    「During the current consolidated fiscal year, the Company's R&D activities focused on the development of environmentally oriented products, mainly through its Technology Development Division. The R&D staff comprised 19 people. R&D expenditure for the current consolidated fiscal year was ¥52.218 million, and R&D activities were as follows:」

    R&D expenditure declined from ¥64.183 million in the previous fiscal year to ¥52.218 million, while specific environmental initiatives were disclosed, including functional coatings for paper, environmentally oriented separators, insulation materials, label-free thermal products, peelable laminates, and products promoting the shift to paper.
  8. FY2024-Q2RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥34.173 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」

    Disclosure of R&D expenditure of ¥34.173 million has continued, together with the statement that there were no material changes in the status of R&D activities.
  9. FY2024-Q1RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥16.816 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」

    Disclosure of R&D expenditure and the continuation of R&D activities have been confirmed, and it is stated that there were no material changes in the status of the activities.
  10. FY2023AdvancedAnnual report

    「R&D expenditure for the current consolidated fiscal year was ¥64.183 million, and R&D activities were as follows:」

    R&D activities continued, and R&D expenditure increased from ¥53.857 million in the previous fiscal year to ¥64.183 million. Development is progressing on thin-wall rigid containers, transparent heat-resistant PET, NC-PET, recycled technologies, bio-PET, and other products.
  11. FY2023-Q3RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥46.837 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」

    R&D activities have continued, with cumulative R&D expenditure for the quarter of ¥46.837 million disclosed, and it is stated that there were no material changes in the status of the activities.
  12. FY2023-Q2R&D expenditure down; activities continuedAnnual report

    「Group-wide R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥29.587 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」

    R&D activities have continued, and there were no material changes in their status, while R&D expenditure declined from ¥32.131 million in the same period of the previous year to ¥29.587 million.
  13. FY2023-Q1R&D expenditure down; activities continuedAnnual report

    「Group-wide R&D expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥13.163 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」

    R&D activities have continued, and there were no material changes in their status, while R&D expenditure declined from ¥14.388 million in the same period of the previous year to ¥13.163 million.
  14. FY2022R&D expenditure down; activities continuedAnnual report

    「R&D expenditure for the current consolidated fiscal year was ¥53.857 million, and R&D activities were as follows:」

    R&D activities and projects including thin-wall rigid containers, transparent heat-resistant PET, NC-PET, NS-PET, foamed PET, and environmental initiatives have continued, but R&D expenditure declined from ¥87.716 million in the previous fiscal year to ¥53.857 million.
  15. FY2022-Q3R&D expenditure down; activities continuedAnnual report

    「Group-wide R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥39.497 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」

    R&D activities have continued, but R&D expenditure declined from ¥54.536 million in the same period of the previous year to ¥39.497 million.
  16. FY2022-Q2R&D expenditure down; activities continuedAnnual report

    「Group-wide R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥25.364 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」

    R&D activities have continued, and it is stated that there were no material changes in their status, while R&D expenditure declined from ¥32.131 million in the same period of the previous year to ¥25.364 million.
  17. FY2022-Q1R&D expenditure down; activities continuedAnnual report

    「Group-wide R&D expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥10.485 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」

    R&D activities have continued, and it is stated that there were no material changes in their status, while R&D expenditure declined from ¥14.388 million in the same period of the previous year to ¥10.485 million.
  18. FY2021R&D spending up, activities continuingAnnual report

    「R&D expenditure for the current consolidated fiscal year was ¥87.716 million, and R&D activities were as follows:」

    R&D activities continued, and R&D expenditure increased from ¥64.604 million in the previous fiscal year to ¥87.716 million. Development has continued on thin-wall rigid containers, transparent heat-resistant PET, NC-PET, NS-PET, NTS III, inkjet technology, foamed PET, environmental initiatives, and other areas.
  19. FY2021-Q3R&D spending up, activities continuingAnnual report

    「Group-wide R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥54.536 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」

    R&D activities continued, and R&D expenditure increased from ¥49.272 million in the same period of the previous year to ¥54.536 million. It is stated that there were no material changes in the status of the activities.
  20. FY2021-Q2R&D expenditure down; activities continuedAnnual report

    「Group-wide R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥32.131 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」

    R&D activities have continued, but R&D expenditure declined from ¥37.035 million in the same period of the previous year to ¥32.131 million.
  21. FY2021-Q1R&D expenditure down; activities continuedAnnual report

    「Group-wide R&D expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥14.388 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」

    R&D activities have continued, but R&D expenditure declined from ¥15.392 million in the same period of the previous year to ¥14.388 million.
  22. FY2020R&D expenditure down; activities continuedAnnual report

    「R&D expenditure for the current consolidated fiscal year was ¥64.604 million, and R&D activities were as follows:」

    R&D has continued on thin-wall rigid containers, transparent heat-resistant PET, NC-PET, NS-PET, NTS III, inkjet technology, foamed PET, environmental initiatives, and other areas, but R&D expenditure declined from ¥67.52 million in the previous fiscal year to ¥64.604 million.
  23. FY2020-Q3R&D expenditure down; activities continuedAnnual report

    「Group-wide R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥49.272 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」

    R&D activities have continued, but R&D expenditure declined from ¥52.511 million in the same period of the previous year to ¥49.272 million. It is stated that there were no material changes in the status of the activities.
  24. FY2020-Q2R&D expenditure down; activities continuedAnnual report

    「Group-wide R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥32.213 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」

    R&D activities have continued, but R&D expenditure declined from ¥37.035 million in the same period of the previous year to ¥32.213 million.
  25. FY2020-Q1R&D expenditure down; activities continuedAnnual report

    「Group-wide R&D expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥15.392 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」

    R&D activities have continued, but R&D expenditure declined from ¥20.277 million in the same period of the previous year to ¥15.392 million.
  26. FY2019R&D expenditure down; activities continuedAnnual report

    「R&D expenditure for the current consolidated fiscal year was ¥67.52 million, and R&D activities were as follows:」

    R&D activities have continued, but R&D expenditure declined from ¥76.387 million in the previous fiscal year to ¥67.52 million. Development has continued on thin-wall rigid containers, heat-resistant PET, NTS III, inkjet technology, nanocellulose, foamed PET, and other products.
  27. FY2019-Q3RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥52.511 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」

    Disclosure of R&D expenditure has continued, and it is stated that there were no material changes in the status of R&D activities.
  28. FY2019-Q2RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥37.035 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」

    Disclosure of R&D expenditure has continued, and it is stated that there were no material changes in the status of R&D activities.
  29. FY2019-Q1RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥20.277 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」

    Disclosure of R&D expenditure has continued, and it is stated that there were no material changes in the status of R&D activities.
  30. FY2018RestatedAnnual report

    「R&D expenditure for the current consolidated fiscal year was ¥76.387 million, and R&D activities were as follows:」

    Disclosure of R&D expenditure has continued, with multiple projects, including thin-wall rigid containers, heat-resistant PET, NS-PET, and inkjet technology, also continuing.
  31. FY2018-Q3RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥56.572 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」

    Disclosure of R&D expenditure has continued, and it is stated that there were no material changes in the status of R&D activities.
  32. FY2018-Q2RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥37.716 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」

    Disclosure of R&D expenditure has continued, and it is stated that there were no material changes in the status of R&D activities.
  33. FY2018-Q1RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥18.261 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」

    Disclosure of R&D expenditure has continued, and it is stated that there were no material changes in the status of R&D activities.
  34. FY2017AdvancedAnnual report

    「R&D expenditure for the current consolidated fiscal year was ¥72.672 million, and R&D activities were as follows: The Company developed a compatibilizer for ternary materials, including PET, during the current fiscal year. The development was successful at the prototype level, but the product has not yet been commercialized.」

    In addition to annual R&D expenditure, specific progress is disclosed, namely that the ternary-material compatibilizer was successful at the prototype level, while it is also explicitly stated that commercialization has not been achieved.
  35. FY2017-Q3RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥53.1 million.」

    Disclosure of R&D activities and expenditure for the cumulative third quarter has continued.
  36. FY2017-Q2RestatedAnnual report

    「Group-wide R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥36.566 million.」

    Disclosure of R&D activities and the related expenditure has continued.
  37. FY2017-Q1First statedAnnual report

    「The Group's research and development expenditures for the first quarter amounted to ¥18,732 thousand.」

    Research and development expenditures for the quarter are disclosed.
Moved together

"First-Quarter Revenue and Earnings Results" moved the same way as this thread, in the same document, in 4 of its 37 moves.

432222★123456
  1. ★This thread
  2. 1First-Quarter Revenue and Earnings Results4×
  3. 2Dividend Payments to Shareholders3×
  4. 3RN Smart Packaging Joint Venture with RICOH COMPANY,LTD.2×
  5. 4Productivity Improvement2×
  6. 5Expansion of the Company's Own Facilities2×
  7. 6Strong Sales of High-Margin Products2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Nakamoto Packs yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.